Xellia Pharmaceuticals ('Xellia') is a global leader in providing critical care therapies and anti-infective treatments against serious and often life-threatening infections; ranging from Active Pharmaceutical Ingredients (APIs) to drug products (FDFs), and from generics to specialty pharmaceuticals. Customers depend on us for reliable supply and consistent quality, and to exemplify responsible manufacturing, production, and research and development that promote long-term sustainability. Headquartered in Copenhagen, Denmark and owned by Novo Holdings A/S, Xellia Pharmaceuticals has more than 1800 employees globally. From state-of-the-art manufacturing sites in the U.S., China, Denmark and Hungary to R&D sites in Norway and Croatia and commercial operations across Europe, Asia, the Middle East and North America; Xellia Pharmaceuticals’ strong market position is built on more than 120 years of pharmaceutical industry experience. With the patient in focus, Xellia is building a pipeline of value-added critical care therapies which aim to enhance patient care by providing convenience and ease of use for healthcare professionals.
View Top Employees from Xellia PharmaceuticalsWebsite | http://www.xellia.com |
Revenue | $363 million |
Employees | 1,303 (1,291 on RocketReach) |
Founded | 1903 |
Address | 11 Dalslandsgade, Copenhagen, Capital Region of Denmark 2300, DK |
Phone | (453) 264-5500 |
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Active Pharmaceutical Ingredients, Healthcare, Drug Discovery, Contract Manufacturing, Finished Dosage Forms, Custom Synthesis |
Web Rank | 1 Million |
Keywords | Pharmaceutical Manufacturing, Pharmaceutical Products, Drug Development And Manufacturing, Anti-Infective Drugs, Pharmaceuticals, Biotechnology, Prescription Drug, Generic Drugs, Specialty Drugs |
Competitors | Hovione, Laurus Labs Limited, Neuland Ireland, Siegfried Holding AG, Vivimed Labs Limited |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Xellia Pharmaceuticals employee's phone or email?
The Xellia Pharmaceuticals annual revenue was $363 million in 2024.
Josip Stopic is the Chief Procurement Officer, Head of Global Procurement and External Supply of Xellia Pharmaceuticals.
1,291 people are employed at Xellia Pharmaceuticals.
Xellia Pharmaceuticals is based in Copenhagen, Capital Region of Denmark.
The NAICS codes for Xellia Pharmaceuticals are [32, 3254, 32541, 325].
The SIC codes for Xellia Pharmaceuticals are [28, 283].